BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 32056965)

  • 41. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Benzodiazepines attenuate the pituitary-adrenal responses to corticotrophin-releasing hormone in healthy volunteers, but not in patients with Cushing's syndrome.
    Korbonits M; Trainer PJ; Edwards R; Besser GM; Grossman AB
    Clin Endocrinol (Oxf); 1995 Jul; 43(1):29-35. PubMed ID: 7641409
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interaction of childhood maltreatment with the corticotropin-releasing hormone receptor gene: effects on hypothalamic-pituitary-adrenal axis reactivity.
    Tyrka AR; Price LH; Gelernter J; Schepker C; Anderson GM; Carpenter LL
    Biol Psychiatry; 2009 Oct; 66(7):681-5. PubMed ID: 19596121
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of hypothalamo-pituitary-adrenocortical function in children by human corticotropin-releasing hormone (MCI-028) test.
    Tanaka T; Hibi I; Shimizu N; Imura H; Tanaka K; Fukata J; Fujieda K; Ichimura T; Kuribayashi T; Ito K
    Endocr J; 1993 Oct; 40(5):581-9. PubMed ID: 7951524
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic-pituitary disorders: comparison between insulin-induced hypoglycemia, low-dose ACTH, standard ACTH and CRH stimulation tests.
    Maghnie M; Uga E; Temporini F; Di Iorgi N; Secco A; Tinelli C; Papalia A; Casini MR; Loche S
    Eur J Endocrinol; 2005 May; 152(5):735-41. PubMed ID: 15879359
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gonadotropin-releasing hormone agonist in premenopausal women does not alter hypothalamic-pituitary-adrenal axis response to corticotropin-releasing hormone.
    Gavin KM; Shea KL; Gibbons E; Wolfe P; Schwartz RS; Wierman ME; Kohrt WM
    Am J Physiol Endocrinol Metab; 2018 Aug; 315(2):E316-E325. PubMed ID: 29631362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modulation of pancreatic islets-stress axis by hypothalamic releasing hormones and 11beta-hydroxysteroid dehydrogenase.
    Schmid J; Ludwig B; Schally AV; Steffen A; Ziegler CG; Block NL; Koutmani Y; Brendel MD; Karalis KP; Simeonovic CJ; Licinio J; Ehrhart-Bornstein M; Bornstein SR
    Proc Natl Acad Sci U S A; 2011 Aug; 108(33):13722-7. PubMed ID: 21825133
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The use of the corticotropin-releasing hormone test to monitor the recovery of patients with Cushing's disease or Cushing's syndrome due to an adrenal adenoma after adenomectomy.
    Hotta MN; Shibasaki T; Suda T; Ling N; Shizume K
    Endocrinol Jpn; 1985 Feb; 32(1):113-25. PubMed ID: 2990881
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress.
    Bale TL; Contarino A; Smith GW; Chan R; Gold LH; Sawchenko PE; Koob GF; Vale WW; Lee KF
    Nat Genet; 2000 Apr; 24(4):410-4. PubMed ID: 10742108
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Corticotropin-releasing hormone-binding protein and stress: from invertebrates to humans.
    Ketchesin KD; Stinnett GS; Seasholtz AF
    Stress; 2017 Sep; 20(5):449-464. PubMed ID: 28436309
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of fetal ethanol exposure on pituitary-adrenal sensitivity to secretagogues.
    Osborn JA; Yu C; Stelzl GE; Weinberg J
    Alcohol Clin Exp Res; 2000 Jul; 24(7):1110-9. PubMed ID: 10924017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2.
    Coste SC; Kesterson RA; Heldwein KA; Stevens SL; Heard AD; Hollis JH; Murray SE; Hill JK; Pantely GA; Hohimer AR; Hatton DC; Phillips TJ; Finn DA; Low MJ; Rittenberg MB; Stenzel P; Stenzel-Poore MP
    Nat Genet; 2000 Apr; 24(4):403-9. PubMed ID: 10742107
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coupling corticotropin-releasing-hormone and angiotensin converting enzyme 2 dampens stress responsiveness in male mice.
    Wang LA; de Kloet AD; Smeltzer MD; Cahill KM; Hiller H; Bruce EB; Pioquinto DJ; Ludin JA; Katovich MJ; Raizada MK; Krause EG
    Neuropharmacology; 2018 May; 133():85-93. PubMed ID: 29360543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intracerebroventricular administration of corticotrophin-releasing hormone receptor antagonists produces different effects on hypothalamic pituitary adrenal responses to novel restraint depending on the stress history of the animal.
    Vining C; Iyer V; Bhatnagar S
    J Neuroendocrinol; 2007 Mar; 19(3):198-207. PubMed ID: 17280593
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Corticotropin releasing factor (CRF)-stimulating test in patients with disorders of the hypothalamo-pituitary-adrenal axis].
    Hashimoto K; Murakami K; Hattore T; Ota Z
    Nihon Naika Gakkai Zasshi; 1984 Sep; 73(9):1317-24. PubMed ID: 6097622
    [No Abstract]   [Full Text] [Related]  

  • 57. Regulation of the hypothalamic-pituitary-adrenocortical system in mice deficient for CRH receptors 1 and 2.
    Preil J; Müller MB; Gesing A; Reul JM; Sillaber I; van Gaalen MM; Landgrebe J; Holsboer F; Stenzel-Poore M; Wurst W
    Endocrinology; 2001 Nov; 142(11):4946-55. PubMed ID: 11606463
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Allopregnanolone reduces neuroendocrine response to acute stressful stimuli in sheep.
    Misztal T; Młotkowska P; Marciniak E; Misztal A
    J Endocrinol; 2020 Jan; 244(1):201-211. PubMed ID: 31600724
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mimecan in pituitary corticotroph cells may regulate ACTH secretion and the HPAA.
    Ma QY; Zhang XN; Jiang H; Wang ZQ; Zhang HJ; Xue LQ; Chen MD; Song HD
    Mol Cell Endocrinol; 2011 Jul; 341(1-2):71-7. PubMed ID: 21664248
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome.
    Newell-Price J; Perry L; Medbak S; Monson J; Savage M; Besser M; Grossman A
    J Clin Endocrinol Metab; 1997 Jan; 82(1):176-81. PubMed ID: 8989255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.